Cargando…

The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients

Migraine is one of the most common primary headache disorders that affects 11% of the adult population. The disease is divided into two main clinical subtypes: migraine with aura (MA) and migraine without aura (MO). Both serotonergic and hypocretinergic systems are involved in the migraine pathomech...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalska, Marta, Kapelusiak-Pielok, Magdalena, Grzelak, Teresa, Wypasek, Ewa, Kozubski, Wojciech, Dorszewska, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996111/
https://www.ncbi.nlm.nih.gov/pubmed/29922128
http://dx.doi.org/10.3389/fnmol.2018.00191
_version_ 1783330766441152512
author Kowalska, Marta
Kapelusiak-Pielok, Magdalena
Grzelak, Teresa
Wypasek, Ewa
Kozubski, Wojciech
Dorszewska, Jolanta
author_facet Kowalska, Marta
Kapelusiak-Pielok, Magdalena
Grzelak, Teresa
Wypasek, Ewa
Kozubski, Wojciech
Dorszewska, Jolanta
author_sort Kowalska, Marta
collection PubMed
description Migraine is one of the most common primary headache disorders that affects 11% of the adult population. The disease is divided into two main clinical subtypes: migraine with aura (MA) and migraine without aura (MO). Both serotonergic and hypocretinergic systems are involved in the migraine pathomechanism. Polymorphisms in the serotonin transporter gene (SLC6A4) and the hypocretin receptor 1 gene (HCRTR1) may be risk factors for migraine development due to their ability to affect serotonin and hypocretin-1 (HCRT-1) concentrations. The aim of the study was to analyze, for the first time in the Polish population, the 5-HT transporter linked polymorphic region (5-HTTLPR) in SLC6A4, G1222A (rs2271933) and the never before studied *G29A (rs41263963) polymorphisms in the HCRTR1 gene, as well as the 5-HT and hypocretin-1 plasma concentrations in migraine patients (MA, MO) and control subjects. The study included 123 patients that were diagnosed with migraine and 123 control subjects. Methods such as PCR, HRMA and sequencing were used for genotyping, while 5-HT was determined by HPLC/EC and hypocretin-1 by ELISA. No significant differences were observed in 5-HTTLPR frequencies. The A allele of HCRTR1 G1222A occurred more often in MO, while the GA genotype of HCRTR1 *G29A was more frequent among MA when compared to control group (p < 0.05). The mean age of migraine onset in individuals with HCRTR1 *G29A was 18 years old for patients with MA and 26 years old for MO patients. The localization and type of HCRTR1 polymorphisms (G1222A—missense variant in exon 7, *G29A−3′UTR variant) may predispose patients to the clinical subtype of migraine: MO or MA, respectively. In control subjects, the short allele of 5-HTTLPR tended to decrease the 5-HT concentration, while the A allele of HCRTR1 G1222A decreased both 5-HT and hypocretin-1 levels. Serotonin concentrations differed in terms of clinical features of migraine. The relation between genotypes of 5-HTTLPR, HCRTR1 G1222A, and 5-HT concentrations may bedisturbed in migraine. It seems that HCRTR1 *G29A is more strongly associated with regulating the 5-HT in patients with MA than MO, and therefore may contribute to the early age of onset for migraine.
format Online
Article
Text
id pubmed-5996111
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59961112018-06-19 The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients Kowalska, Marta Kapelusiak-Pielok, Magdalena Grzelak, Teresa Wypasek, Ewa Kozubski, Wojciech Dorszewska, Jolanta Front Mol Neurosci Neuroscience Migraine is one of the most common primary headache disorders that affects 11% of the adult population. The disease is divided into two main clinical subtypes: migraine with aura (MA) and migraine without aura (MO). Both serotonergic and hypocretinergic systems are involved in the migraine pathomechanism. Polymorphisms in the serotonin transporter gene (SLC6A4) and the hypocretin receptor 1 gene (HCRTR1) may be risk factors for migraine development due to their ability to affect serotonin and hypocretin-1 (HCRT-1) concentrations. The aim of the study was to analyze, for the first time in the Polish population, the 5-HT transporter linked polymorphic region (5-HTTLPR) in SLC6A4, G1222A (rs2271933) and the never before studied *G29A (rs41263963) polymorphisms in the HCRTR1 gene, as well as the 5-HT and hypocretin-1 plasma concentrations in migraine patients (MA, MO) and control subjects. The study included 123 patients that were diagnosed with migraine and 123 control subjects. Methods such as PCR, HRMA and sequencing were used for genotyping, while 5-HT was determined by HPLC/EC and hypocretin-1 by ELISA. No significant differences were observed in 5-HTTLPR frequencies. The A allele of HCRTR1 G1222A occurred more often in MO, while the GA genotype of HCRTR1 *G29A was more frequent among MA when compared to control group (p < 0.05). The mean age of migraine onset in individuals with HCRTR1 *G29A was 18 years old for patients with MA and 26 years old for MO patients. The localization and type of HCRTR1 polymorphisms (G1222A—missense variant in exon 7, *G29A−3′UTR variant) may predispose patients to the clinical subtype of migraine: MO or MA, respectively. In control subjects, the short allele of 5-HTTLPR tended to decrease the 5-HT concentration, while the A allele of HCRTR1 G1222A decreased both 5-HT and hypocretin-1 levels. Serotonin concentrations differed in terms of clinical features of migraine. The relation between genotypes of 5-HTTLPR, HCRTR1 G1222A, and 5-HT concentrations may bedisturbed in migraine. It seems that HCRTR1 *G29A is more strongly associated with regulating the 5-HT in patients with MA than MO, and therefore may contribute to the early age of onset for migraine. Frontiers Media S.A. 2018-06-05 /pmc/articles/PMC5996111/ /pubmed/29922128 http://dx.doi.org/10.3389/fnmol.2018.00191 Text en Copyright © 2018 Kowalska, Kapelusiak-Pielok, Grzelak, Wypasek, Kozubski and Dorszewska. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Kowalska, Marta
Kapelusiak-Pielok, Magdalena
Grzelak, Teresa
Wypasek, Ewa
Kozubski, Wojciech
Dorszewska, Jolanta
The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title_full The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title_fullStr The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title_full_unstemmed The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title_short The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients
title_sort new *g29a and g1222a of hcrtr1, 5-httlpr of slc6a4 polymorphisms and hypocretin-1, serotonin concentrations in migraine patients
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996111/
https://www.ncbi.nlm.nih.gov/pubmed/29922128
http://dx.doi.org/10.3389/fnmol.2018.00191
work_keys_str_mv AT kowalskamarta thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT kapelusiakpielokmagdalena thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT grzelakteresa thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT wypasekewa thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT kozubskiwojciech thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT dorszewskajolanta thenewg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT kowalskamarta newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT kapelusiakpielokmagdalena newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT grzelakteresa newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT wypasekewa newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT kozubskiwojciech newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients
AT dorszewskajolanta newg29aandg1222aofhcrtr15httlprofslc6a4polymorphismsandhypocretin1serotoninconcentrationsinmigrainepatients